Decrease in acute coronary syndrome presentations during the COVID-19 pandemic in upstate New York - 16/08/20
, Wajeeh ur Rehman, MD b, Md Alom, MD b, Vincent Skovira, MD a, Nour Breiteh, BSc, MPH c, Ibraheem Rehman, BSc d, Alon Yarkoni, MD a, Hisham Kahsou, MD a, Afzal Rehman, MD a
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Introduction |
The COVID-19 virus is a devastating pandemic that has impacted the US healthcare system significantly. More than one study reported a significant decrease in acute coronary syndrome admissions during that pandemic which is still due to unknown reasons.
Methods |
This is a retrospective non-controlled multi-centered study of 180 patients (117 males and 63 females) with acute coronary syndrome (STEMI and NSTEMI) admitted during March/April of 2019 and March/April 2020 in Upstate New York.
Results |
A total of 113 patients (61.9% males, 38.1% females) with a mean age of 72.3 ± 14.2 presented during March/April 2019 with ACS (STEMI + NSTEMI) while only 67 (70.1% males, 29.9% females) COVID-19 negative patients with a mean age of 65.1 ± 14.5 presented during the same period (March/April) in 2020. This is a drop by 40.7% (P < .05) of total ACS cases during the COVID-19 pandemic. In NSTEMI patients, 36.4% presented late (>24 hours of symptoms) during the COVID-19 pandemic in comparison with 2019 (27.1%, P = .033).
Conclusion |
The COVID-19 pandemic led to a substantial drop by 40.7% (P < .05) of total ACS admissions in our area. This decrease in hospital admissions and late presentations can be a worrisome sign for an increase in future complications of myocardial infarctions.
Il testo completo di questo articolo è disponibile in PDF.Mappa
| Declarations of interest: None |
|
| Submission declaration: Our work described has not been published previously and is not under consideration for publication elsewhere. This paper is approved by all authors and by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. The authors are solely responsible for the design and conduct of this study, all study analyses, the drafting and editing of the manuscript, and its final contents. |
|
| Funding No extramural funding was used to support this work. |
Vol 226
P. 147-151 - Agosto 2020 Ritorno al numero
Articolo precedente
- Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center
- Hesham K. Abdelaziz, Amr Abdelrahman, Amjad Nabi, Maciej Debski, Amgad Mentias, Tawfiq Choudhury, Billal Patel, Marwan Saad
- Use and outcomes of wearable cardioverter-defibrillators in a large integrated academic health system
- Peter A. Kahn, Jadry Gruen, Alex Thomas, Tariq Ahmad, Nihar R. Desai
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.